Targeting Mutant AKT in Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2015-160
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Cancer Therapeutic Targeting Using Mutant–p53-Specific siRNAs

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Targeting Autophagy in BRAF-Mutant Tumors

Cancer Discovery
Oncology
2015English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Targeting MUC1-C Inhibits the AKT-S6K1-elF4A Pathway Regulating TIGAR Translation in Colorectal Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Maspin Modulates Prostate Cancer Cell Apoptotic and Angiogenic Response to Hypoxia via Targeting AKT

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy